TruScreen Group Ltd. stock analysis
Want to see NZ:TRU full AI Analyst Report?
TruScreen Group Ltd. (TRU) Stock Price & Analysis
TRU Stock Chart & Stats
- Day’s Range
- NZD 0.01 - NZD 0.01
- 52-Week Range
- NZD 0.01 - NZD 0.02
- Previous Close
- NZD 0.01
- Volume
- N/A
- Average Volume (3M)
- 587.23K
- Market Cap
- NZD 9.43M
- Enterprise Value
- NZD 11.44M
- Total Cash (Recent Filing)
- NZD 1.46M
- Total Debt (Recent Filing)
- NZD 200.69K
- Price to Earnings (P/E)
- ―
- Beta
- -0.13
- Next Earnings
- Nov 26, 2026 (Est.)
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Revenue Rebound
The strong FY2026 revenue rebound indicates renewed demand for TruScreen’s products and improved commercial traction. If maintained, higher sales can expand the installed base, support distributor and screening-program relationships, and provide a larger foundation for eventual operating leverage.
Modest Leverage
Low leverage and positive equity provide the company with more balance-sheet resilience than a highly indebted medical-device business. This reduces immediate debt-service pressure and preserves greater flexibility to fund commercialization, although profitability and cash generation still need to improve.
Point-of-Care Screening Model
A portable, point-of-care cervical screening system addresses a defined access problem in healthcare settings that may lack laboratory infrastructure. This positioning can broaden the addressable market across clinics, hospitals, and screening programs while supporting recurring consumables use.
Bears Say
Gross Margin Collapse
The sharp gross-margin deterioration shows that recent revenue growth has not translated into healthy unit economics. At approximately 1% margin, little revenue remains to fund research, commercial activity, administration, or future growth, making the business model difficult to scale sustainably.
Persistent Losses
Large net losses and deeply negative returns on equity indicate that the company is still consuming shareholder capital rather than generating sustainable earnings. Continued losses can weaken the capital base over time and limit the resources available for product development and market expansion.
Negative Cash Generation
Persistent operating and free-cash-flow deficits mean reported losses are translating into genuine cash burn. The further FY2026 deterioration increases reliance on future funding or stronger sales execution, creating a durable constraint on investment capacity and financial flexibility.
TruScreen Group Ltd. News
TRU FAQ
What was TruScreen Group Ltd.’s price range in the past 12 months?
What is TruScreen Group Ltd.’s market cap?
When is TruScreen Group Ltd.’s upcoming earnings report date?
How were TruScreen Group Ltd.’s earnings last quarter?
Is TruScreen Group Ltd. overvalued?
Does TruScreen Group Ltd. pay dividends?
What is TruScreen Group Ltd.’s EPS estimate?
How many shares outstanding does TruScreen Group Ltd. have?
What happened to TruScreen Group Ltd.’s price movement after its last earnings report?
Which hedge fund is a major shareholder of TruScreen Group Ltd.?
What is the TipRanks Smart Score and how is it calculated?
Company Description
TruScreen Group Ltd.
TruScreen Group Limited, alongside its subsidiaries, focuses on the development, manufacturing, and global distribution of advanced systems for cancer detection. Their commercial reach extends across various international territories, including Mexico, China, Russia, Vietnam, Zimbabwe, countries within Eastern Europe, the Middle East/North Africa region, and beyond. A flagship product is the TruScreen cervical cancer screening system, a specialized medical device engineered to provide real-time identification of precancerous and cancerous tissue present on the cervix. Established in 2013, the company, with its primary base of operations in Auckland, New Zealand, officially changed its name from TruScreen Limited to Truscreen Group Limited in August 2020.
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Martin Dillon
- Employees
- 6
- Website
- truscreen.com
- Address
- Equitable House, Auckland, AU, 1010, NZ
TruScreen Group Ltd. (TRU) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 2 | 6 | 14 |
| Technical Analysis | 2 | 6 | 2 |
| Moving Averages | 0 | 0 | 12 |








